Inventor · disambiguated record
Isabelle Carlavan
Also filed as: CARLAVAN ISABELLE
3 granted patents·19 pending applications·1 citations·filing 2005–2021
50Inventor score
Top patents by PatentIndex Score
22 records- 0163US2021404004A1Th17 differentiation markers for acne and uses thereofGALDERMA RES & DEV·Filed 2021·Application pending·0 cites
- 0261US9889126B2Use of naratriptan in the treatment of rosaceaGALDERMA RES & DEV·Filed 2014·Granted Feb 13, 2018·0 cites·16 claims
- 0357US8962846B2Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmeticsBOUIX-PETER CLAIRE·Filed 2009·Granted Feb 24, 2015·0 cites·18 claims
- 0456US2011263677A1Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 0555US10760129B2Th17 differentiation markers for acne and uses thereofGALDERMA RES & DEV·Filed 2016·Granted Sep 1, 2020·1 cites·15 claims
- 0654US2011268742A1Pctp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 0750US2016326590A1Th17 differentiation markers for acne and uses thereofGALDERMA RES & DEV·Filed 2016·Application pending·0 cites
- 0849US2014221648A1Th17 differentiation markers for acne and uses thereofCARLAVAN ISABELLE·Filed 2012·Application pending·0 cites
- 0949US2010168089A1Utilization of tace inhibitors for the treatment of acneGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1048US2009246776A1Modulators of scarb-1 for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1148US2010028878A1Modulators of UDP-glucose ceramide glucosyltransferase for treating acne or hyperkeratinizationGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1247US2011189686A1Screening for modulators of cyp2b15 and/or gpd1 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1347US2016326587A1Ovol1 as a new marker for moderate to severe acneKING S COLLEGE LONDON·Filed 2014·Application pending·0 cites
- 1447US2016319353A1Ap5b1 as a new marker for moderate to severe acneKING S COLLEGE LONDON·Filed 2014·Application pending·0 cites
- 1546US2009258356A1Modulators of the transporter ABCD3 for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1645US2010021892A1Modulators of SC4MOL for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1739US2006052627A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 1839US2014329809A1New leukocyte infiltrate markers for rosacea and uses thereofGALDERMA RES & DEV·Filed 2012·Application pending·0 cites
- 1938US2006035969A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 2036US2014275108A1Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsGALDERMA RES & DEV·Filed 2013·Application pending·0 cites
- 2135US2014235475A1Th17 differentiation markers for acne and uses thereofCARLAVAN ISABELLE·Filed 2012·Application pending·0 cites
- 2234US2015329522A1Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmeticsGALDERMA RES & DEV·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →